Veterinary Vaccines Market Size and Future Analysis 2028
兽医疫苗市场规模预计将从 2021 年的 99.8465 亿美元增至 2028 年的 155.3638 亿美元;预计 2021 年至 2028 年的复合年增长率为 6.5%。
兽用疫苗是用于预防由各种病原体引起的传染病的肠外产品。这些疫苗可保护动物免受各种危及生命的疾病的侵害。兽用疫苗在确保宠物和牲畜的寿命、健康和整体生产方面发挥着关键作用,且具有成本效益。兽用疫苗分为灭活疫苗、减毒活疫苗、类毒素疫苗和重组疫苗。推动市场增长的关键因素是人畜共患疾病发病率的增加以及食源性疾病和感染的患病率的上升。然而,政府对兽用疫苗使用的严格规定阻碍了市场的增长。按地区划分,兽用疫苗市场分为北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美和中美 (SAM)。由于伴侣动物的收养增加、肉类和牛奶消费增加以及对动物免疫益处的了解增加,北美在全球市场占据主导地位。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
兽医疫苗市场:
Veterinary Vaccines Market: Strategic Insights
Veterinary Vaccines Market
-
CAGR (2021 - 2028)
6.5%
-
Market Size 2021
US$ 9.98 Billion
-
Market Size 2028
US$ 15.54 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Boehringer Ingelheim International GmbH
- MERCK
- Zoetis Services LLC
- Elanco
- Vetoquinol
- Ceva
- Virbac
- NEOGEN Corporation
- Biovac
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
疫苗类型(牲畜疫苗(牛疫苗和小反刍动物疫苗)
伴侣动物疫苗(猫疫苗、犬疫苗等)
技术(减毒活疫苗、灭活疫苗、类毒素疫苗、重组疫苗、结合疫苗等)
Veterinary Vaccines Market: Strategic Insights
-
CAGR (2021 - 2028)6.5% -
Market Size 2021
US$ 9.98 Billion -
Market Size 2028
US$ 15.54 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Boehringer Ingelheim International GmbH
- MERCK
- Zoetis Services LLC
- Elanco
- Vetoquinol
- Ceva
- Virbac
- NEOGEN Corporation
- Biovac
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2021 - 2028 年)6.5%- 2021 年市场规模
99.8 亿美元 - 2028 年市场规模
155.4 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 勃林格殷格翰国际有限公司
- 默克
- 硕腾服务有限公司
- 礼来
- 维托喹诺尔
- 塞瓦
- 维克
- Neogen 公司
- 比奥瓦克
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 牲畜疫苗
- 猫疫苗
- 犬疫苗
- 其他的
- 减毒活疫苗
- 灭活疫苗
- 类毒素疫苗
- 重组疫苗
- 结合疫苗
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察
人畜共患疾病发病率上升
动物会将有害的细菌、病毒、寄生虫和真菌传播给人类,导致人类患病。这类疾病被称为人畜共患疾病。人畜共患疾病的临床效果可能从轻微到严重不等,有时甚至会导致死亡。人畜共患疾病在世界各地随处可见。根据疾病控制中心 (CDC) 的预测,人类现有的每 10 种传染病中就有 6 种以上可以通过动物传播,而每 4 种新的或未来的人类传染病中就有 3 种来自动物。此外,2016 年,亚洲和非洲至少有 55,000 人死于狂犬病。
在过去的几十年中,几种导致人类感染的新型病毒,如埃博拉病毒、西尼罗河病毒、人类免疫缺陷病毒 (HIV)、尼帕病毒和汉坦病毒感染,都是从动物宿主进化而来的。严重急性呼吸综合征 (SARS) 和禽流感等疫情的爆发凸显了动物宿主病菌适应人类宿主的潜力。21 世纪初新出现、出现或重新出现的人类疾病中,超过四分之三是由来自动物或动物产品的病原体引起的。据世界卫生组织统计,全球发现的约 60% 的新传染病是人畜共患疾病,每年有超过 10 亿例疾病和数百万例死亡是由人畜共患疾病引起的。在过去的三十年中,已经发现了 30 多种新型人类感染,其中 75% 源自动物。因此,新出现和重新出现的人畜共患疾病推动了对动物健康的需求。因此,公司生产改进的药物和疫苗,以帮助动物主人或其他利益相关者维持动物的整体健康。因此,人畜共患疾病发病率的增长推动了兽医疫苗市场的增长。
基于疫苗类型的见解
根据疫苗类型,全球兽用疫苗市场分为牲畜疫苗、伴侣动物疫苗和其他疫苗。牲畜疫苗领域很可能在 2021 年占据最大的市场份额。然而,预计伴侣动物领域在预测期内的复合年增长率最高,为 7.0%。
基于技术的见解
根据技术,全球兽用疫苗市场分为减毒活疫苗、灭活疫苗、类毒素疫苗、重组疫苗、结合疫苗等。2021 年,减毒活疫苗领域可能占据最大的市场份额。然而,灭活疫苗领域预计将在 2021 年至 2028 年期间以最高复合年增长率增长。
兽用疫苗市场参与者采用有机策略,例如产品推出和扩张,以扩大其全球影响力和产品组合并满足日益增长的需求。
地理
从地理上看,兽用疫苗市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非和 MEA 其他地区)以及南美洲和中美洲(巴西、阿根廷和 SCAM 其他地区)。
兽医疫苗市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 99.8亿美元 |
2028 年市场规模 | 155.4亿美元 |
全球复合年增长率(2021 - 2028) | 6.5% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按疫苗类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
新冠疫情影响
由于 COVID-19 疫情,欧洲各国受到了严重影响。为了控制病毒的爆发,政府实施了各种限制措施。这导致每个行业的每个部门都受到干扰、限制、挑战和变化。同样,动物疫苗行业也受到了疫情的影响。例如,海外兽医组织建议将动物患者护理限制在急性病动物和紧急情况下。此外,封锁导致重新安排年度体检和选择性疫苗接种程序。
然而,由于全球各国政府机构采取严格措施维持供应,避免人畜共患病毒传播到社区,各主要参与者已确保动物疫苗的供应。然而,COVID-19 对动物疫苗市场的整体影响仍然相当负面,原因是由于兽医就诊次数有限,动物保健方法转变为为紧急情况和重病动物提供护理,导致需求下降。
公司简介
- 勃林格殷格翰国际有限公司
- 默克
- 硕腾服务有限公司
- 礼来
- 维托喹诺尔
- 塞瓦
- 维克
- Neogen 公司
- 比奥瓦克
- ImmuCell 公司
Veterinary Vaccines Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 9.98 Billion |
Market Size by | US$ 15.54 Billion |
Global CAGR | 6.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 疫苗类型(牲畜疫苗(牛疫苗和小反刍动物疫苗) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Veterinary Vaccines market is anticipated to grow around 6.5% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2021.
Boehringer Ingelheim International GmbH and Zoetis Inc., are the key players in the Veterinary Vaccines market.
Livestock vaccines segment market provides the most opportunity for growth.
Key factors that are driving growth of the market are increasing incidence of zoonotic diseases and rising prevalence foodborne diseases and infections propel the market growth. However, strict government rules related to the usage of veterinary vaccines hamper the growth of the market.
A Veterinary Vaccines is a sterile glass or plastic test tube with a stopper that creates a vacuum inside the tube so that a preset volume of liquid can be depicted. The Veterinary Vaccines prevents needle stick damage by preventing needles from coming in human contact and thus, adulteration. A double-pointed needle is fitted to a plastic tubular adapter in the vacuum blood collecting tube. Double pointed needles are available in numerous gauge sizes. The needle's length varies from 1 to 1 1/2 inches. Additional elements may be present in Veterinary Vacciness, which are used to preserve blood for treatment in a medical laboratory.
The List of Companies - Veterinary Vaccines Market
- Boehringer Ingelheim International GmbH
- MERCK
- Zoetis Services LLC
- Elanco
- Vetoquinol
- Ceva
- Virbac
- NEOGEN Corporation
- Biovac
- ImmuCell Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.